| scholarly article | Q13442814 |
| P50 | author | Andrew K Godwin | Q89896596 |
| Dionyssios Katsaros | Q114421372 | ||
| P2093 | author name string | Karthik Devarajan | |
| Harsh B Pathak | |||
| George Coukos | |||
| Nathalie Scholler | |||
| Rachel Hammond | |||
| Phyllis A Gimotty | |||
| Raphael Sandaltzopoulos | |||
| Dimitra Sasaroli | |||
| Eleni Kougioumtzidou | |||
| Ron Buckanovich | |||
| P2860 | cites work | Genes expressed in human tumor endothelium | Q24290105 |
| Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1 | Q24291650 | ||
| Adhesion signaling by a novel mitotic substrate of src kinases | Q24594187 | ||
| VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche | Q24600542 | ||
| Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine | Q24605725 | ||
| Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 | ||
| Cell surface tumor endothelial markers are conserved in mice and humans | Q28216392 | ||
| Matriptase and its putative role in cancer | Q28275949 | ||
| Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma | Q28288817 | ||
| Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
| Role of angiogenesis in tumor growth and metastasis | Q29614309 | ||
| Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment | Q33240538 | ||
| Tumor vascular proteins as biomarkers in ovarian cancer | Q33275925 | ||
| Molecular characterization of human breast tumor vascular cells | Q33327647 | ||
| TSG-6: a pluripotent inflammatory mediator? | Q34527768 | ||
| Vascular gene expression in nonneoplastic and malignant brain. | Q35103013 | ||
| Vascular-targeting therapies for treatment of malignant disease. | Q35805639 | ||
| Imaging angiogenesis: applications and potential for drug development | Q36027611 | ||
| Disrupting tumour blood vessels | Q36146900 | ||
| Tumour vascular targeting | Q36146905 | ||
| CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma | Q36691145 | ||
| Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging | Q37758596 | ||
| The glycan profile of endothelial cells in the present of tumor-conditioned medium and potential roles of beta-1,6-GlcNAc branching on HUVEC conformation | Q43142190 | ||
| Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy | Q43851616 | ||
| Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice | Q44427355 | ||
| Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer | Q45106840 | ||
| Expression of MAEG, a novel basement membrane protein, in mouse hair follicle morphogenesis. | Q45168428 | ||
| Angiogenesis | Q56689455 | ||
| Activation of human endothelial cells by tumor necrosis factor-α results in profound changes in the expression of glycosylation-related genes | Q57261985 | ||
| Alterations in Vascular Gene Expression in Invasive Breast Carcinoma | Q57281019 | ||
| Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience | Q60651985 | ||
| Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer | Q61857359 | ||
| Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer | Q61889874 | ||
| The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis | Q71656440 | ||
| Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A | Q80501633 | ||
| Vascular leukocytes contribute to tumor vascularization | Q80546906 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| biomarker | Q864574 | ||
| P304 | page(s) | 169-80 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | Novel surface targets and serum biomarkers from the ovarian cancer vasculature | |
| P478 | volume | 12 |
| Q36958112 | A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer. |
| Q48002665 | ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling |
| Q38880697 | ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma. |
| Q37184585 | Association of Immunosuppression with DR6 Expression during the Development and Progression of Spontaneous Ovarian Cancer in Laying Hen Model |
| Q36748713 | Death receptor 6 (DR6) is required for mouse B16 tumor angiogenesis via the NF-κB, P38 MAPK and STAT3 pathways |
| Q58796822 | Death receptor 6 promotes ovarian cancer cell migration through KIF11 |
| Q36199847 | Expression of death receptor 6 by ovarian tumors in laying hens, a preclinical model of spontaneous ovarian cancer. |
| Q64906465 | FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas. |
| Q33789691 | FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC. |
| Q37696286 | Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics |
| Q40867070 | Identification of a Peptide from In vivo Bacteriophage Display with Homology to EGFL6: A Candidate Tumor Vasculature Ligand in Breast Cancer |
| Q35677838 | Identification of novel vascular targets in lung cancer |
| Q64092279 | Serum biomarker panels for the diagnosis of gastric cancer |
| Q34893030 | T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression. |
| Q37679962 | Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature. |
| Q30417587 | Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model |
| Q40214132 | Vascular marker expression during the development of various types of gynaecological malignancy |
| Q94562656 | miR-6086 inhibits ovarian cancer angiogenesis by downregulating the OC2/VEGFA/EGFL6 axis |
Search more.